乙酰膽堿酯酶(ACHE)多克隆抗體(生物素標(biāo)記)
Biotin-Linked Polyclonal Antibody to Acetylcholinesterase (ACHE)
ARAChE; N-AChE; YT
- 編號(hào)LAB447Hu71
- 物種Homo sapiens (Human，人) 相同的名稱(chēng)，不同的物種。
- 來(lái)源抗體標(biāo)記
- Ig類(lèi)型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 659 ¥ 1537 ¥ 2196 ¥ 5490 ¥ 21960
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)ACHE的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ACHE。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶(hù)決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB447Hu01 | 乙酰膽堿酯酶(ACHE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB447Hu01 | 乙酰膽堿酯酶(ACHE)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB447Hu71 | 乙酰膽堿酯酶(ACHE)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB447Hu21 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu26 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu27 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu22 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu23 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu24 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB447Hu25 | 乙酰膽堿酯酶(ACHE)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB447Hu | 乙酰膽堿酯酶(ACHE)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB447Hu | 乙酰膽堿酯酶(ACHE)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Acta Histochem Cytochem. | The Effects of Exercise-induced Fatigue on Acetylcholinesterase Expression and Activity at Rat Neuromuscular Junctions [PubMed: PMC2775104] |
| Applied Biological Chemistry | Positive enhancement of Lactobacillus fermentum HY01 on intestinal movements of mice having constipation [10.1007/s13765-017-0327-3] |
| Molecular Nutrition &?Food?Research | Thymoquinone Can Improve Neuronal Survival and Promote Neurogenesis in Rat Hippocampal Neurons [Pubmed:29277983] |
| Inflammation | Feishu Acupuncture Inhibits Acetylcholine Synthesis and Restores Muscarinic Acetylcholine Receptor M2 Expression in the Lung When Treating Allergic Asthma [Pubmed:29520557] |
| International Journal of Molecular Sciences | In Vitro Evaluation and Docking Studies of 5-oxo-5H-furo [3, 2-g] chromene-6-carbaldehyde Derivatives as Potential Anti-Alzheimer's Agents [Pubmed: 31683761] |
| BMC Anesthesiology | Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a?… [Pubmed: 32988385] |
| PHYTOMEDICINE | Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat?… [Pubmed: 32920292] |
| PLoS One | Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats [Pubmed:35421180] |
| scientific reports | Neuropsychopharmacological profiling of scoparone in mice [Pubmed:35039558] |
| SAUDI J BIOL SCI | Aqueous Ajwa dates seeds extract improves memory impairment in type-2 diabetes mellitus rats by reducing blood glucose levels and enhancing brain?… [Pubmed:35531250] |
| Saudi Pharmaceutical Journal | Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic?… [Pubmed:35812141] |
